| 产品详情 |
| Edit |   |
| Product Name | COTI-2 |
| Description | Purity >95%. COTI-2 is an orally available thiosemicarbazone that activates mutant forms of p53. It induces apoptosis in a wide variety of human tumor cells in culture, inhibits the proliferation of colorectal cancer cell lines more effectively than cetuximab and erlotinib , and is active against human glioblastoma cell lines at nanomolar concentrations. COTI-2 functions well in vivo, inhibiting the growth of HT-29 colorectal, SHP-77 small cell lung cancer, and OVCAR-3 ovarian carcinoma xenograft cells in mice with minimal toxicity. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 4-(2-pyridinyl)-2-(6,7-dihydro-8(5H)-quinolinylidene)hydrazide-1-piperazinecarbothioic acid |
| Gene, Accession, CAS # | CAS: 1039455-84-9 |
| Catalog # | LS-H7237 |
| Price | |
| Order / More Info | COTI-2 from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|